US-based Juno Therapeutics purchased a German biotech
Juno Therapeutics has purchased Stage Cell Therapeutics, a privately held biotechnology company, based in Munich…
12/05/2015 - 2 minutes
CAR-T
Cardio3, the leading Stem Cell Biotech gets a US patent on CAR-T
Just a week after announcing its intention to launch an IPO in the United States,…
08/04/2015 - 2 minutes
Gene editing to make French fries less unhealthy
A promising biotechnological approach or an innovative way of avoiding regulation? Large companies spend an…
06/04/2015 - 4 minutes
Merck Serono and Intrexon, to develop CAR-T Therapy
Merck Sereno, the biopharmaceutical business of Merck, and the synthetic biology leader Intrexon announced yesterday an exclusive strategic…
31/03/2015 - 2 minutes
With €200 Million, Cellectis is on its way to make the Biggest French Biotech IPO ever
Exactly one month ago, the article "Cellectis is preparing its IPO in the U.S" explained…
26/03/2015 - 2 minutes
Review: The CRISPR’s Therapeutical revolution
Six years ago, a new sophisticated prokaryotic defense system, was identified in the structure complex…
21/01/2015 - 4 minutes
